Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Aortic Interventions: Features

Video
Promoting Hemodynamic Stability Throughout TEVAR Procedures Minimizes “Windsocking” and Other Challenges
09/01/2022
What defines conformability for TEVAR?
What defines conformability for TEVAR?
What defines conformability...
09/01/2022
Vascular Disease Management
Video
What Is a Device Manufacturer’s Role Beyond Providing Products, as a Source of Integral Support?
08/05/2022
Supporting customer needs together.
Supporting customer needs together.
Supporting customer needs...
08/05/2022
Vascular Disease Management
Video
Ross Milner, MD: Iliac Branch Clinical Trial and GREAT Registry Outcomes
07/06/2022
Dr. Ross Milner looks at the outcomes of the Gore Excluder Iliac Branch IBE clinical trial and GREAT Registry in combination.
Dr. Ross Milner looks at the outcomes of the Gore Excluder Iliac Branch IBE clinical trial and GREAT Registry in combination.
Dr. Ross Milner looks at the...
07/06/2022
Vascular Disease Management
Clinical Images
Arterial Dissection With a Vascular Closure Device
06/17/2022
The authors review a case where a dissection in the right CFA was caused by the foot plate of a vascular closure device.
The authors review a case where a dissection in the right CFA was caused by the foot plate of a vascular closure device.
The authors review a case where...
06/17/2022
Vascular Disease Management
Dr. Eleshra
LINC 2022
Single-Center Results of Endovascular Repair in Patients With Marfan Syndrome
06/10/2022
Ahmed Eleshra, MD, a vascular surgeon from Mansoura, Egypt, provides data on single-center results of endovascular repair for patients with Marfan Syndrome.
Ahmed Eleshra, MD, a vascular surgeon from Mansoura, Egypt, provides data on single-center results of endovascular repair for patients with Marfan Syndrome.
Ahmed Eleshra, MD, a vascular...
06/10/2022
Vascular Disease Management
Dr. Branzan
LINC 2022
The Role of 3D Printing in the Treatment of Urgent Complex Aortic Pathologies
06/10/2022
Daniela Branzan, MD describes her work in 3D printing of custom-made stent grafts.
Daniela Branzan, MD describes her work in 3D printing of custom-made stent grafts.
Daniela Branzan, MD describes...
06/10/2022
Vascular Disease Management
Dr. Azizzadeh
LINC 2022
Endovascular Rescue for Blunt Trauma Aortic Injury
06/10/2022
Dr. Ali Azizzadeh discusses the outcomes of a trial to assess thoracic endovascular repair in blunt traumatic aortic injury.
Dr. Ali Azizzadeh discusses the outcomes of a trial to assess thoracic endovascular repair in blunt traumatic aortic injury.
Dr. Ali Azizzadeh discusses the...
06/10/2022
Vascular Disease Management
Dr. Riambau
LINC 2022
How Sac Regression at 1 Year Affects All-Cause Mortality Through 8 Years: Key Insights From the ENGAGE Registry
06/09/2022
Presented by Vicente Riambau, MD. 
Presented by Vicente Riambau, MD. 
Presented by Vicente Riambau,...
06/09/2022
Vascular Disease Management
Dr. Marc van Sambeek
LINC 2022
EXCeL Registry Post-Market Study on Angulated Necks
06/09/2022
The latest results from the important EXCeL registry by Marc van Sambeek, MD.
The latest results from the important EXCeL registry by Marc van Sambeek, MD.
The latest results from the...
06/09/2022
Vascular Disease Management
Dr. Steinbauer
LINC 2022
CERAB Emerges as the Aortoiliac Favorite
06/09/2022
Dr. Markus Steinbauer discusses the use of covered stents in complex aortoiliac peripheral artery occlusive disease lesions.
Dr. Markus Steinbauer discusses the use of covered stents in complex aortoiliac peripheral artery occlusive disease lesions.
Dr. Markus Steinbauer discusses...
06/09/2022
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement